Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund's adjuvant, with or without peptide.

MLA

Salerno, Elise P., et al. “Activation, Dysfunction and Retention of T Cells in Vaccine Sites after Injection of Incomplete Freund’s Adjuvant, with or without Peptide.” Cancer Immunology, Immunotherapy : CII, vol. 62, no. 7, July 2013, pp. 1149–59. EBSCOhost, https://doi.org/10.1007/s00262-013-1435-5.

APA

Salerno, E. P., Shea, S. M., Olson, W. C., Petroni, G. R., Smolkin, M. E., McSkimming, C., Chianese-Bullock, K. A., & Slingluff, C. L., Jr. (2013). Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide. Cancer Immunology, Immunotherapy : CII, 62(7), 1149–1159. https://doi.org/10.1007/s00262-013-1435-5

Chicago

Salerno, Elise P, Sofia M Shea, Walter C Olson, Gina R Petroni, Mark E Smolkin, Chantel McSkimming, Kimberly A Chianese-Bullock, and Craig L Slingluff Jr. 2013. “Activation, Dysfunction and Retention of T Cells in Vaccine Sites after Injection of Incomplete Freund’s Adjuvant, with or without Peptide.” Cancer Immunology, Immunotherapy : CII 62 (7): 1149–59. doi:10.1007/s00262-013-1435-5.